GXMC
MDCO

Global X Management Company’s Medicines Co MDCO Stock Holding History

Global X Management Company’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-682
Closed -$22K – 1209
2018
Q1 		$22K Buy
682
+31
+5% +$969 ﹤0.01% 1112
2017
Q4 		$18K Buy
651
+169
+35% +$5.21K ﹤0.01% 1031
2017
Q3 		$18K Buy
482
+10
+2% +$369 ﹤0.01% 1078
2017
Q2 		$18K Sell
472
-110
-19% -$4.9K ﹤0.01% 1173
2017
Q1 		$28K Buy
+582
New +$26.5K ﹤0.01% 1010
2015
Q4 		– Sell
-393
Closed -$15K – 984
2015
Q3 		$15K Sell
393
-118
-23% -$4.14K ﹤0.01% 532
2015
Q2 		$15K Sell
511
-224
-30% -$6.24K ﹤0.01% 525
2015
Q1 		$21K Sell
735
-112
-13% -$3.15K ﹤0.01% 462
2014
Q4 		$23K Hold
847
– – ﹤0.01% 440
2014
Q3 		$19K Buy
+847
New +$21.5K ﹤0.01% 482

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Global X Management Company's MDCO Position: Q2 2018 in Review

Global X Management Company sold out of Medicines Co (MDCO) in Q2 2018, closing a stake of 682 shares — an estimated $22K sold.

Global X Management Company first reported a position in MDCO in Q3 2014 and held it in 10 quarters. The position peaked at $28K in Q1 2017. 188 funds tracked by Wall St. Rank hold MDCO as of Q2 2018.

  • Global X Management Company reported no remaining Medicines Co position as of Q2 2018 after selling out during the quarter.
  • Global X Management Company sold 682 Medicines Co shares in Q2 2018, an estimated $22K.
  • Global X Management Company first reported a position in Medicines Co in Q3 2014 and held it in 10 quarters.
  • Global X Management Company's Medicines Co position peaked at $28K in Q1 2017.
  • 188 funds tracked by Wall St. Rank held Medicines Co as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.